Nicoletta Pescalli

CEP-18770: A novel, orally active proteasome inhibitor with a tumor-selective pharmacologic profile competitive with bortezomib

Roberto Piva, Bruce Ruggeri, Michael Williams et al. · Blood · 2007 · 253 citations · Full text

Medicine, Oncology, Pharmacology +9

2,3-Dihydro-1<i>H</i>,7<i>H</i>-pyrimido[5,6,1-<i>d</i><i>e</i>]acridine-1,3,7-trione Derivatives, a Class of Cytotoxic Agents Active on Multidrug-Resistant Cell Lines:  Synthesis, Biological Evaluation, and Structure−Activity Relationships

Ippolito Antonini, Paolo Polucci, Lloyd R. Kèlland et al. · Journal of Medicinal Chemistry · 1999 · 68 citations

Medicine, Medicinal Chemistry, Pharmacology +14

Design, Synthesis, and Biological Properties of New Bis(acridine-4-carboxamides) as Anticancer Agents

Ippolito Antonini, Paolo Polucci, Amelia Magnano et al. · Journal of Medicinal Chemistry · 2003 · 60 citations

Pharmacy, Medicinal Chemistry, Pharmacology +9

1-[(ω-Aminoalkyl)amino]-4-[<i>N</i>-(ω-aminoalkyl)carbamoyl]-9-oxo-9,10-dihydro- acridines as Intercalating Cytotoxic Agents:  Synthesis, DNA Binding, and Biological Evaluation

Ippolito Antonini, Paolo Polucci, Terence C. Jenkins et al. · Journal of Medicinal Chemistry · 1997 · 46 citations

Medicine, Chemistry, Oncology +13

Cytotoxicity evaluation of natural coptisine and synthesis of coptisine from berberine

Maria Laura Colombo, Carlo Bugatti, Andrea Mossa et al. · Il Farmaco · 2001 · 37 citations

Pharmacy, Pharmacology, Toxicology +9